SYSTEMS AND METHODS FOR COMPUTER RECOGNITION OF 3D GESTURE MOVEMENTS

    公开(公告)号:WO2022208168A1

    公开(公告)日:2022-10-06

    申请号:PCT/IB2022/000168

    申请日:2022-03-30

    Applicant: FISCH, Martin

    Inventor: FISCH, Martin

    Abstract: Systems and methods described herein enable automated motion recognition by receiving a time-series of images depicting a subject at a plurality of time points. For each image in the time-series of images, an orientation key-point associated with a section of a body part of the subject are predicted via a neural network detector, a three-axis joint rotation associated with the section of the body part is computed based on the orientation key-point associated with the body part and a joint key -point associated with the body part, and features are generated including at least one of: the orientation key-point, the joint key-point, or the three-axis joint rotation. A motion performed by the subject is predicted via a motion recognition machine learning model based on the features of each image in the time-series of images, and an operation is executed in response to the motion.

    IMAGE ANALYSIS FOR AUTOMATED MONITORING OF SWELLING AND/OR ATROPHY OF BODY PARTS

    公开(公告)号:WO2023275214A1

    公开(公告)日:2023-01-05

    申请号:PCT/EP2022/068006

    申请日:2022-06-29

    Inventor: HÜGLE, Thomas

    Abstract: The invention relates to a method for determining a parameter indicative of the degree of swelling, atrophy and/or fibrosis of a body part of a subject and/or a method for determining a score indicative of the state of arthritis, scleroderma and/or Raynaud´s phenomenon from an image of a body part. The invention further relates to a pharmaceutical composition for use in the treatment of arthritis, scleroderma and/or Raynaud´s phenomenon in a subject, wherein the subject has a score indicative for an active state of arthritis, scleroderma and/or Raynaud´s phenomenon determined according to method of the invention. The invention also relates to a library of a parameter indicative of the degree of swelling atrophy and/or fibrosis determined according to the method of the invention or of a score indicative of the state of arthritis, scleroderma and/or Raynaud´s phenomenon determined according to the method of the invention.

Patent Agency Ranking